Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, July 15, 2009

MBC, MassEcon rates cities, towns for biotech; Lowell ranks highest

By Mass High Tech staff

In its second round of municipality ratings, the Massachusetts Biotechnology Council and MassEcon have rated seven communities as “BioReady” — that is, ready to be marketed to biotechnology companies seeking relocation or expansion.

Among the ratings, Lowell achieved the sole platinum level; Chelmsford, Marlborough and Somerville received silver ratings; and Newton, Hatfield and Norfolk received bronze ratings. In total, MBC and MassEcon have rated 51 communities since the BioReady Communities Campaign was launched in Massachusetts in 2008.

According to the BioReady Community Campaign web site, the marketing tool acknowledges efforts cities and towns have made to “adopt local policies that greatly ease the pathway for renovation or new construction of biotech laboratory and manufacturing facilities.” Among the noted efforts favoring the biotechnology industry are public infrastructure projects, pre-permitted biotech sites, expedited permitting policies, by-right zoning and planned area developments.






 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.